Viola Previtali

Kongens Lyngby, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

The novel agent VP79s synergistically enhances venetoclax activity in multiple myeloma cells.

The novel agent VP79s synergistically enhances venetoclax activity in multiple myeloma cells.

Journal: Investigational new drugs

Published: May 22, 2026

New allosteric modulators of molecular chaperone TRAP1 from the integration of computational biology, medicinal chemistry, and biophysics.

New allosteric modulators of molecular chaperone TRAP1 from the integration of computational biology, medicinal chemistry, and biophysics.

Journal: Cell stress & chaperones

Published: February 13, 2026

Targeting RAD51-BRCA2 Interaction to Enhance Synthetic Lethality with Olaparib in Pancreatic Cancer: Development of a Novel Phenyl Furan-Quinoline-Carboxylic Acid Series.

Targeting RAD51-BRCA2 Interaction to Enhance Synthetic Lethality with Olaparib in Pancreatic Cancer: Development of a Novel Phenyl Furan-Quinoline-Carboxylic Acid Series.

Journal: ACS medicinal chemistry letters

Published: November 26, 2025

Platinum(ii) complexes of aryl guanidine-like derivatives as potential anticancer agents: between coordination and cyclometallation.

Platinum(ii) complexes of aryl guanidine-like derivatives as potential anticancer agents: between coordination and cyclometallation.

Journal: RSC advances

Published: January 13, 2025

Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity.

Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity.

Journal: Cell death discovery

Published: October 14, 2024

New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives.

New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives.

Journal: Journal of medicinal chemistry

Published: July 02, 2024

Alligamycin A, an antifungal β-lactone spiroketal macrolide from Streptomyces iranensis.

Alligamycin A, an antifungal β-lactone spiroketal macrolide from Streptomyces iranensis.

Journal: Nature communications

Published: April 29, 2024

An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer.

An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer.

Journal: European journal of medicinal chemistry

Published: October 27, 2023

Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer.

Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer.

Journal: Angewandte Chemie (International ed. in English)

Published: August 25, 2023

Preomic profile of BxPC-3 cells after treatment with BRC4.

Preomic profile of BxPC-3 cells after treatment with BRC4.

Journal: Journal of proteomics

Published: April 11, 2023

Novel Insights into RAD52's Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies.

Novel Insights into RAD52's Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies.

Journal: Cancers

Published: February 08, 2023

Sulochrins and alkaloids from a fennel endophyte Aspergillus sp. FVL2.

Sulochrins and alkaloids from a fennel endophyte Aspergillus sp. FVL2.

Journal: Natural product research

Published: December 06, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026